Literature DB >> 8724982

Effect of nucleus accumbens dopamine depletion on motivational aspects involved in initiation of cocaine and heroin self-administration in rats.

M A Gerrits1, J M Van Ree.   

Abstract

The involvement of mesolimbic dopamine (DA) systems in motivational aspects of drug-taking behavior during initiation of drug self-administration was investigated using a recently developed behavioral paradigm. In separate experiments animals were allowed to self-administer cocaine or heroin (0.16 and 0.32 mg . kg-1 per inf) during 5 consecutive daily 3-h sessions. During a 15-min period preceding the last four self-administration sessions lever-press behavior was measured in absence of the drug as an index of the motivational aspects involved in drug-taking behavior. The effect of 6-hydroxydopamine (6-OHDA) lesion of the nucleus accumbens (NAC) on lever-press behavior before and during self-administration was measured. Destruction of DA terminals in the NAC did not affect initiation of heroin self-administration nor the lever-press behavior during the period preceding the self-administration sessions. In cocaine animals 6-OHDA lesion of the NAC decreased the total intake of cocaine during the self-administration sessions and impaired discriminative lever-responding for the drug, both during cocaine self-administration, and during preceding periods when no cocaine was available. It is concluded that DAergic systems in the NAC might be involved in the reinforcement and/or motivational processes underlying cocaine self-administration. The present findings, however, do not support the notion of a critical role of NAC DA in the motivational aspects of drug-taking behavior in general.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8724982     DOI: 10.1016/0006-8993(95)01491-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  23 in total

1.  Unidirectional relationship between heroin self-administration and impulsive decision-making in rats.

Authors:  Maria C Schippers; Rob Binnekade; Anton N M Schoffelmeer; Tommy Pattij; Taco J De Vries
Journal:  Psychopharmacology (Berl)       Date:  2011-09-02       Impact factor: 4.530

2.  Distinct contributions of dopamine in the dorsolateral striatum and nucleus accumbens shell to the reinforcing properties of cocaine.

Authors:  Maartje M J Veeneman; Mark H Broekhoven; Ruth Damsteegt; Louk J M J Vanderschuren
Journal:  Neuropsychopharmacology       Date:  2011-09-14       Impact factor: 7.853

Review 3.  Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons.

Authors:  Stephan Steidl; David I Wasserman; Charles D Blaha; John S Yeomans
Journal:  Neurosci Biobehav Rev       Date:  2017-09-23       Impact factor: 8.989

4.  Differential vulnerability to relapse into heroin versus cocaine-seeking as a function of setting.

Authors:  Christian Montanari; Emiliana Stendardo; Maria Teresa De Luca; Maria Meringolo; Laura Contu; Aldo Badiani
Journal:  Psychopharmacology (Berl)       Date:  2015-02-10       Impact factor: 4.530

Review 5.  Exercise as a novel treatment for drug addiction: a neurobiological and stage-dependent hypothesis.

Authors:  Wendy J Lynch; Alexis B Peterson; Victoria Sanchez; Jean Abel; Mark A Smith
Journal:  Neurosci Biobehav Rev       Date:  2013-06-24       Impact factor: 8.989

Review 6.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

7.  Kappa Opioid Receptor-Mediated Disruption of Novel Object Recognition: Relevance for Psychostimulant Treatment.

Authors:  Jason J Paris; Kate J Reilley; Jay P McLaughlin
Journal:  J Addict Res Ther       Date:  2011-12-24

8.  Roles of dopaminergic innervation of nucleus accumbens shell and dorsolateral caudate-putamen in cue-induced morphine seeking after prolonged abstinence and the underlying D1- and D2-like receptor mechanisms in rats.

Authors:  Jun Gao; Yonghui Li; Ning Zhu; Stephen Brimijoin; Nan Sui
Journal:  J Psychopharmacol       Date:  2012-11-13       Impact factor: 4.153

9.  Individual differences in orexin-I receptor modulation of motivation for the opioid remifentanil.

Authors:  Kirsten A Porter-Stransky; Brandon S Bentzley; Gary Aston-Jones
Journal:  Addict Biol       Date:  2015-11-24       Impact factor: 4.280

10.  Dopamine D3 receptor ligands modulate the acquisition of morphine-conditioned place preference.

Authors:  Henriette Francès; Maria Smirnova; Ludovic Leriche; Pierre Sokoloff
Journal:  Psychopharmacology (Berl)       Date:  2004-04-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.